Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-21 · accession 0001735276-21-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-23 | 2021-12-22 | ALNY | MARAGANORE JOHN | CEO, Dir | F - Tax | $188.98 | -6,636 | 228.0K | -3% | -$1.25M |
| 2021-12-23 | 2021-12-21 | ALNY | MARAGANORE JOHN | CEO, Dir | A - Grant | $0.00 | +14.2K | 234.3K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | F | D | 6,315 | $189.13 | 227,984 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-21 | A | A | 14,167 | $0.00 | 234,299 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-22 | F | D | 319 | $186.02 | 227,663 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-22 | F | D | 2 | $190.50 | 227,982 | D | — | — |